Aurora Cannabis Inc [ACB] stock is trading at $4.39, down -7.58%. An important factor to consider is whether the stock is rising or falling in short-term value. The ACB shares have gain 14.32% over the last week, with a monthly amount glided 35.91%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 20, March 2024, Aurora Cannabis Achieves Australia’s TGA GMP Certification, Setting Global Standard for Quality and Compliance. In a post published today on Yahoo Finance, Milestone Achievement Signals Company’s Commitment to Solidifying its Leadership in the Australian Market.
From an analyst’s perspective:
Aurora Cannabis Inc [NASDAQ: ACB] stock has seen the most recent analyst activity on February 09, 2024, when Canaccord Genuity upgraded its rating to a Buy. Previously, Canaccord Genuity upgraded its rating to Hold on September 21, 2022. On June 24, 2022, upgrade upgraded it’s rating to Overweight. Stifel upgraded its rating to a Hold. MKM Partners upgraded its rating to a Neutral. Jefferies upgraded its rating to Hold for this stock on September 03, 2021, and downed its price target to $6.78. In a note dated May 14, 2021, BMO Capital Markets upgraded an Market Perform rating on this stock.
Aurora Cannabis Inc [ACB] stock has fluctuated between $2.84 and $11.50 over the past year. Currently, Wall Street analysts expect the stock to reach $5.92 within the next 12 months. Aurora Cannabis Inc [NASDAQ: ACB] shares were valued at $4.39 at the most recent close of the market. An investor can expect a potential return of 34.85% based on the average ACB price forecast.
Analyzing the ACB fundamentals
Aurora Cannabis Inc [NASDAQ:ACB] reported sales of 203.84M for the trailing twelve months, which represents a growth of 4.10%. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at -0.46%, Pretax Profit Margin comes in at -0.76%, and Net Profit Margin reading is -0.7%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.32 and Total Capital is -0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.13 points at the first support level, and at 3.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.82, and for the 2nd resistance point, it is at 5.25.
Aurora Cannabis Inc [ACB] reported earnings per share of -$0.37 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.07/share, meaning a difference of -$0.3 and a surprise factor of -428.60%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0 per share as compared to estimates of -$0.29 per share, a difference of $0.29 representing a surprise of 100.00%.
Ratios To Look Out For
For context, Aurora Cannabis Inc’s Current Ratio is 3.79. On the other hand, the Quick Ratio is 2.45, and the Cash Ratio is 1.34. Considering the valuation of this stock, the price to sales ratio is 0.34, the price to book ratio is 0.53 and price to earnings (TTM) ratio is 0.48.
